Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Belite Bio, Inc - American Depositary Shares (NQ: BLTE )

29.67 -2.18 (-6.84%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,471
Open 31.66
Bid (Size) 24.00 (5)
Ask (Size) 34.99 (1)
Prev. Close 31.85
Today's Range 29.50 - 31.66
52wk Range 11.00 - 36.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
Expert Ratings for Belite Bio
Via Benzinga

Performance

YTD
-0.44%
-0.44%
1 Month
-14.99%
-14.99%
3 Month
+107.48%
+107.48%
6 Month
+4.07%
+4.07%
1 Year
+1.96%
+1.96%

More News

Read More
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
From Belite Bio, Inc
Via GlobeNewswire
The Latest Analyst Ratings for Belite Bio
Via Benzinga
Analyst Expectations for Belite Bio's Future
Via Benzinga
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
From Belite Bio, Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Why Shares of Belite Bio Are Slumping Wednesday
Via The Motley Fool
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
From Belite Bio, Inc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Via Benzinga
Belite Bio Completes Enrollment in Pivotal Global Phase 3 DRAGON Trial Evaluating Oral Tinlarebant for Stargardt Disease
From Belite Bio, Inc
Via GlobeNewswire
Why Shares of Belite Bio Soared This Week
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Top 5 Health Care Stocks That Are Set To Fly In Q2
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views
Via Benzinga
Dow Tumbles Over 200 Points; Chicago PMI Drops In May
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
HP, Ambarella, Sportsmans Warehouse And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.